Tom Frohlich Aerovate Therapeutics, Inc. (AVTE) insider trading activity

AVTE Quotes by TradingView

Tom Frohlich is Chief Executive Officer of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 6,000 shares of AVTE, which is worth approximately $16,080. The most recent transaction as insider was on May 16, 2025, when has been sold 6,000 shares (Common Stock) at a price of $7.4 per share, resulting in proceeds of $44,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
n/a 3M change
n/a 12M change
Total Value Held $16,080

Tom Frohlich Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2025
BUY
Open market or private purchase
$44,400 $7.4 p/Share
6,000 Added 50.0%
6,000 Common Stock

Also insider at

KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
Chief Operating Officer
TF

Tom Frohlich

Chief Executive Officer
Seattle, WA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTE